Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurologic Manifestations 1 Brain Neoplasms 1

Interventions

Temozolomide 162 Radiosurgery 114 Radiotherapy 99 Bevacizumab 95 Magnetic Resonance Spectroscopy 64 Carboplatin 48 Etoposide 34 Surgical Procedures, Operative 33 Irinotecan 33 pembrolizumab 32 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 29 Carmustine 28 Cisplatin 25 Lomustine 24 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Pliability × Clear all

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡